Ependymomas: development of immunotherapeutic strategies.
about
The fine structure of ependymomas.STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.Antigenic expression and spontaneous immune responses support the use of a selected peptide set from the IMA950 glioblastoma vaccine for immunotherapy of grade II and III glioma.
P2860
Ependymomas: development of immunotherapeutic strategies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ependymomas: development of immunotherapeutic strategies.
@en
Ependymomas: development of immunotherapeutic strategies.
@nl
type
label
Ependymomas: development of immunotherapeutic strategies.
@en
Ependymomas: development of immunotherapeutic strategies.
@nl
prefLabel
Ependymomas: development of immunotherapeutic strategies.
@en
Ependymomas: development of immunotherapeutic strategies.
@nl
P2093
P2860
P1476
Ependymomas: development of immunotherapeutic strategies
@en
P2093
Hideho Okada
Ian F Pollack
Regina I Jakacki
P2860
P304
P356
10.1586/14737175.2013.840420
P577
2013-10-01T00:00:00Z